SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-19-001240
Filing Date
2019-05-28
Accepted
2019-05-28 18:11:42
Documents
1
Period of Report
2019-05-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3619
  Complete submission text file 0001593968-19-001240.txt   5085
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 828 BALMORAL LN NORTHBROOK IL 60062
Business Address
ROTHERMEL ROBERT B (Reporting) CIK: 0001277431 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 19858993